ALOX15 and gastric cancer: Cisplatin and paclitaxel promote miR-522 secretion which decreases the accumulation of lipid-ROS by suppressing ALOX15 expression and ultimately results in chemoresistance in gastric cancer (Zhang H. et al., 2020).